Increased expression of osteopontin is associated with long-term bee venom immunotherapy

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 5, 2005, Pages 1063-1067

  Konno, Satoshi ^a   Golden, David B K ^a   Schroeder, John ^a   Hamilton, Robert G ^a   Lichtenstein, Lawrence M ^a   Huang, Shau Ku ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Biomarker; Clustering; Gene chip microarray; Osteopontin; Venom immunotherapy

Indexed keywords

BEE VENOM; MOLECULAR MARKER; OSTEOPONTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DEVICE; DNA MICROARRAY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INSECT ALLERGY; LONG TERM CARE; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UPREGULATION;

EID: 18144389419     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.01.055     Document Type: Article

References (24)

1. D.B.K. Golden, K.A. Kwiterovich, A. Kagey-Sobotka, M.D. Valentine, and L.M. Lichtenstein Discontinuing venom immunotherapy: outcome after five years J Allergy Clin Immunol 97 1996 579 587
2. D.B.K. Golden, K.A. Kwiterovich, A. Kagey-Sobotka, and L.M. Lichtenstein Discontinuing venom immunotherapy: extended observations J Allergy Clin Immunol 101 1998 298 305
3. D.B.K. Golden Stinging insect vaccines Immunol Allergy Clin North Am 20 2000 553 570
4. A.B. Wilson, J. Deighton, P.J. Lachmann, and P.W. Ewan A comparative study of IgG subclass antibodies in patient allergic to wasp or bee venom Allergy 49 1994 272 280
5. D.B.K. Golden, I.D. Lawrence, R.H. Hamilton, A. Kagey-Sobotka, M.D. Valentine, and L.M. Lichtenstein Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy J Allergy Clin Immunol 90 1992 386 393
6. S.J. Till, J.N. Francis, K. Nouri-Aria, and S.R. Durham Mechanisms of immunotherapy J Allergy Clin Immunol 113 2004 1025 1034
7. J.M. Portnoy, J.E. Moffitt, D.B. Golden, I.L. Bernstein, W.E. Berger, and M.S. Dykewicz Stinging insect hypersensitivity: a practice parameter J Allergy Clin Immunol 103 1999 963 980
8. R.G. Hamilton, D.B.K. Golden, K.A. Kwiterovich, A. Kagey-Sobotka, and L.M. Lichtenstein Case report of venom immunotherapy for a patient with large local reactions Ann Allergy Asthma Immunol 87 2001 134 137
9. X.Q. Yu, J.M. Fan, D.J. Nikolic-Paterson, N. Yang, W. Mu, and R. Pichler IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat Am J Pathol 154 1999 833 841
10. A.B. Tuck, D.M. Arsenault, F.P. O'Malley, C. Hota, M.C. Ling, and S.M. Wilson Osteopontin induces increased invasiveness and plasminogen activator expression of human epithelial cells Oncogene 18 1999 4237 4246
11. Y. Koguchi, K. Kawakami, S. Kon, T. Segawa, M. Maeda, and T. Uede Penicillium marneffei causes osteopontin-mediated production of interleukin-12 by peripheral blood mononuclear cells Infect Immun 70 2001 1042 1048
12. N. Yamamoto, F. Sakai, S. Kon, J. Morimoto, C. Kimura, and H. Yamazaki Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis J Clin Invest 112 2003 181 188
13. X. Li, A.W. O'Regan, and J.S. Berman IFN-g induction of osteopontin expression in human monocytoid cells J Interferon Cytokine Res 23 2003 259 265
14. S. Ashkar, G.F. Weber, V. Panoutsakopoulou, M.E. Sanchirico, M. Jansson, and S. Zawaideh Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity Science 287 2000 860 864
15. Y. Miyazaki, T. Tashiro, Y. Higuchi, M. Setoguchi, S. Yamamoto, and H. Nagai Expression of osteopontin in a macrophage cell line and in transgenic mice with pulmonary fibrosis resulting from the lung expression of a tumor necrosis factor-alpha transgene Ann N Y Acad Sci 21 1995 334 341
16. M. Mazzali, T. Kipari, V. Ophascharoensuk, J.A. Wesson, R. Johnson, and J. Hughes Osteopontin - a molecule for all seasons Q J Med 95 2002 3 13
17. H. Cantor The role of Eta-1/osteopontin in the pathogenesis of immunological disorders Ann N Y Acad Sci 760 1995 143 150
18. T. Uede, Y. Katagiri, J. Iizuka, and M. Murakami Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein? Microbiol Immunol 41 1997 641 648
19. S. Ashkar, G.F. Weber, V. Panoutsakopoulou, M.E. Sanchirico, M. Jansson, and S. Zawaideh Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity Science 287 2000 860 864
20. D. Chabas, S.E. Baranzini, D. Mitchell, C.C.A. Bernard, S.R. Rittling, and D.T. Denhardt The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease Science 294 2001 1731 1735
21. M. Jansson, V. Panoutsakopoulou, J. Baker, L. Klein, and H. Cantor Cutting edge: attenuated experimental autoimmune encephalomyelitis in Eta-1/osteopontin-deficient mice J Immunol 168 2002 2096 2099
22. K. Yumoto, M. Ishijima, S.R. Rittling, K. Tsuji, Y. Tsuchiya, and S. Kon Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice Proc Natl Acad Sci U S A 99 2000 4556 4561
23. A.W. O'Regan, J.M. Hayden, and J.S. Berman Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells J Leukoc Biol 68 2000 495 502
24. J. Chehimi, M. Elder, J. Greene, L. Noroski, E.R. Stiehm, and J.A. Winkelstein Cytokine and chemokine dysregulation in hyper-IgE syndrome Clin Immunol 100 2001 49 56